Marsh & McLennan Companies (NYSE:MRSH) Price Target Cut to $190.00 by Analysts at Mizuho

Marsh & McLennan Companies (NYSE:MRSH) had its price objective reduced by stock analysts at Mizuho from $201.00 to $190.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. Mizuho’s price target points to a potential upside of 9.67% from the company’s previous close.

Several other analysts also recently issued reports on MRSH. UBS Group lifted their target price on Marsh & McLennan Companies from $216.00 to $222.00 and gave the company a “buy” rating in a research note on Tuesday. Wells Fargo & Company increased their price objective on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the company an “equal weight” rating in a report on Wednesday, July 22nd. JPMorgan Chase & Co. raised their target price on shares of Marsh & McLennan Companies from $212.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, October 1st. Weiss Ratings upgraded shares of Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 7th. Finally, Cantor Fitzgerald increased their price objective on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Two investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Marsh & McLennan Companies presently has a consensus rating of “Hold” and an average target price of $202.12.

Marsh & McLennan Companies Price Performance

Shares of MRSH stock traded up $1.50 on Wednesday, hitting $173.24. 749,893 shares of the stock traded hands, compared to its average volume of 2,800,800. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22. Marsh & McLennan Companies has a 52 week low of $156.60 and a 52 week high of $207.82. The business has a 50 day moving average price of $183.30. The stock has a market cap of $82.67 billion, a price-to-earnings ratio of 21.17, a price-to-earnings-growth ratio of 2.37 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.89 by $0.07. The business had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The company’s revenue was up 6.2% on a year-over-year basis. Sell-side analysts forecast that Marsh & McLennan Companies will post 10.43 EPS for the current year.

Insiders Place Their Bets

In related news, SVP Paul Beswick sold 713 shares of Marsh & McLennan Companies stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the transaction, the senior vice president owned 16,376 shares in the company, valued at approximately $3,242,448. This trade represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Lloyd M. Yates sold 12,000 shares of the company’s stock in a transaction that occurred on Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total value of $2,107,800.00. Following the sale, the director owned 12,001 shares in the company, valued at approximately $2,107,975.65. This trade represents a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 19,813 shares of company stock valued at $3,597,903 in the last three months. Corporate insiders own 0.38% of the company’s stock.

Institutional Trading of Marsh & McLennan Companies

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Solstein Capital LLC purchased a new position in Marsh & McLennan Companies during the fourth quarter worth $25,000. Asset Dedication LLC bought a new stake in shares of Marsh & McLennan Companies in the 1st quarter worth about $25,000. SHP Wealth Management purchased a new position in shares of Marsh & McLennan Companies during the 4th quarter worth about $26,000. Pinnacle Bancorp Inc. bought a new position in Marsh & McLennan Companies during the 1st quarter valued at about $28,000. Finally, Canton Hathaway LLC purchased a new stake in Marsh & McLennan Companies in the 1st quarter worth about $28,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through four principal businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman.

Marsh is an insurance brokerage and risk adviser that helps clients identify, manage and transfer risk. Guy Carpenter provides reinsurance brokerage and advisory services to insurance companies.